Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progressioan

被引:0
|
作者
Mikhail G Dozmorov
Joseph T Azzarello
Jonathan D Wren
Kar-Ming Fung
Qing Yang
Jeffrey S Davis
Robert E Hurst
Daniel J Culkin
Trevor M Penning
Hsueh-Kung Lin
机构
[1] Oklahoma Medical Research Foundation,Arthritis & Clinical Immunology Program
[2] University of Oklahoma Health Sciences Center,Department of Urology
[3] University of Oklahoma Health Sciences Center,Department of Physiology
[4] University of Oklahoma Health Sciences Center,Department of Pathology
[5] Oklahoma City Department of Veterans Affairs Medical Center,Department of Biochemistry and Molecular Biology
[6] University of Oklahoma Health Sciences Center,Center of Excellence in Environmental Toxicology, Department of Pharmacology
[7] University of Pennsylvania School of Medicine,undefined
来源
BMC Cancer | / 10卷
关键词
Vascular Endothelial Growth Factor; Androgen Receptor; Vascular Endothelial Growth Factor Expression; LNCaP Cell; Vascular Endothelial Growth Factor mRNA Expression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progressioan
    Dozmorov, Mikhail G.
    Azzarello, Joseph T.
    Wren, Jonathan D.
    Fung, Kar-Ming
    Yang, Qing
    Davis, Jeffrey S.
    Hurst, Robert E.
    Culkin, Daniel J.
    Penning, Trevor M.
    Lin, Hsueh-Kung
    BMC CANCER, 2010, 10
  • [2] Elevated expression of AKR1C2 and AKR1C3 in prostate cancer cells promotes angiogenesis in vitro
    Azzarello, Joseph
    Wang, Shaobin
    Fung, Kar-Ming
    Kropp, Bradley P.
    Lin, Hsueh-Kung
    JOURNAL OF UROLOGY, 2008, 179 (04): : 457 - 457
  • [3] Activin A Stimulates AKR1C3 Expression and Growth in Human Prostate Cancer
    Hofland, Johannes
    van Weerden, Wytske M.
    Steenbergen, Jacobie
    Dits, Natasja F. J.
    Jenster, Guido
    de Jong, Frank H.
    ENDOCRINOLOGY, 2012, 153 (12) : 5726 - 5734
  • [4] AKR1C3 as a target in castrate resistant prostate cancer
    Adeniji, Adegoke O.
    Chen, Mo
    Penning, Trevor M.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 137 : 136 - 149
  • [5] CELL-MEDIATED CYTOTOXICITY IN PATIENTS WITH CANCER OF THE PROSTATE
    OKABE, T
    ACKERMANN, R
    WIRTH, M
    FROHMULLER, HGW
    JOURNAL OF UROLOGY, 1979, 122 (05): : 628 - 632
  • [6] Lipid degradation promotes prostate cancer cell survival
    Itkonen, Harri M.
    Brown, Michael
    Urbanucci, Alfonso
    Tredwell, Gregory
    Lau, Chung Ho
    Barfeld, Stefan
    Hart, Claire
    Guldvik, Ingrid J.
    Takhar, Mandeep
    Heemers, Hannelore V.
    Erho, Nicholas
    Bloch, Katarzyna
    Davicioni, Elai
    Derua, Rita
    Waelkens, Etienne
    Mohler, James L.
    Clarke, Noel
    Swinnen, Johan V.
    Keun, Hector C.
    Rekvig, Ole P.
    Mills, Ian G.
    ONCOTARGET, 2017, 8 (24) : 38264 - 38275
  • [7] Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: Implications for prostate carcinogenesis and progression of prostate cancer
    Zhao, ZG
    Shen, W
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (07) : 414 - 419
  • [8] EVALUATING THE EFFICACY OF A NOVEL AKR1C3 INHIBITOR IN PATIENT-DERIVED PROSTATE CANCER CELL LINE AND XENOGRAFT MODELS
    Yang, Joy C.
    Ning, Shu
    Adomat, Hans
    Gleave, Martin
    Gao, Allen C.
    Evans, Christopher P.
    Liu, Chengfei
    JOURNAL OF UROLOGY, 2022, 207 (05): : E452 - E453
  • [9] Role of AKR1C3 in converting reservoirs of DHEA-S into potent androgens that drive prostate cancer cell growth
    Detlefsen, Andrea J.
    Duan, Ling
    Mesaros, Clementina
    Penning, Trevor M.
    CANCER RESEARCH, 2023, 83 (07)
  • [10] Cell-Mediated Autophagy Promotes Cancer Cell Survival
    Buchser, William J.
    Laskow, Thomas C.
    Pavlik, Philip J.
    Lin, Hui-Min
    Lotze, Michael T.
    CANCER RESEARCH, 2012, 72 (12) : 2970 - 2979